卡替洛尔

卡替洛尔（CAS 51781-06-7）的公开数据库记录，列此仅供独立核对。

物理形态与操作说明

• Solid

公开数据库收录的理化数据

这个物质在各数据库里的编号

数据库记载的用途

• For the treatment of intraocular hypertension and chronic open-angle glaucoma
• Breast Feeding; Lactation; Milk, Human; Adrenergic Beta-Antagonists; Antiglaucoma Agents
• Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
• Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
• Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
• Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.

它在各数据库里的别名

CARTEOLOL; 51781-06-7; Carteololum; 8NF31401XG; 2(1H)-Quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-; CHEBI:3437; DTXSID3022746; 5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydroquinolin-2-one; carteololo; 5-(3-(tert-butylamino)-2-hydroxypropoxy)-3,4-dihydroquinolin-2-ol; 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinolin-2-ol; 5-(3-(tert-butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinolin-2-one; RefChem:58563; DTXCID202746; C07AA15; S01ED05

计算机算出的分子描述符

数据库摘要

Carteolol · CAS 51781-06-7 · C16H24N2O3. UNII 8NF31401XG. 溶解度: 4.21e-01 g/L; LogP: 1.1; LogP: 1.49.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。